[Extended spectrum beta lactamase forming pathogens (ESBL)]

Med Klin Intensivmed Notfmed. 2012 Nov;107(8):592-3. doi: 10.1007/s00063-012-0185-z.

[Article in German]

Author

Affiliation

¹ Charité – Universitätsmedizin Berlin, Campus Benjamin Franklin, Institut für Hygiene und Umweltmedizin, Hindenburgdamm 27, Berlin. petra.gastmeier@charite.de

PMID: 23138656
DOI: 10.1007/s00063-012-0185-z

No abstract available

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Bacterial Infections / drug therapy*
Bacterial Infections / microbiology*
Bacterial Infections / transmission
Community-Acquired Infections / drug therapy*
Community-Acquired Infections / microbiology*
Community-Acquired Infections / transmission
Cross Infection / drug therapy*
Cross Infection / microbiology*
Cross Infection / transmission
Cross-Sectional Studies
Drug Resistance, Multiple, Bacterial*
Germany
Gram-Negative Bacterial Infections / drug therapy
Gram-Negative Bacterial Infections / microbiology
Gram-Negative Bacterial Infections / transmission
Humans
Intensive Care Units
beta-Lactam Resistance*
beta-Lactamases / metabolism*

Substances

Anti-Bacterial Agents
beta-Lactamases